Track the GE HealthCare Technologies Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €29.4bn. The latest transaction was filed on 1 May 2026 (Acquisition). Among the most active insiders: Rott Roland. All data is accessible without an account.
190
Insider Decl.
n/a
Thresholds
€615,738
5 ops.
Buy Volume
€2m
7 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate GE HealthCare Technologies Inc. Buy (bullish), based on 19 analysts. Average price target: US$78.95.
50Σ signal
Buys €615,738€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,463 of 28,169 companies
63.2
score / 100
Value
64
Quality
63
FCF yld4.7%
Earn yld6.5%
EV/EBITDA11.2x
ROE19%
Gross mgn40%
Net mgn10%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
558 shares@ US$78.972.3% of flowCommon Stock, par value $0.01 per shareSEC:0001952159-26-000002:0
25 of 190 declarations
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is a company focused on healthcare technologies, providing innovative solutions for diagnosis and treatment. It operates on the XNAS market.